26 min listen
The American College of Cardiology Meeting: Nexlotol, Push Ablation and More!
The American College of Cardiology Meeting: Nexlotol, Push Ablation and More!
ratings:
Length:
26 minutes
Released:
Mar 17, 2023
Format:
Podcast episode
Description
Thank you for your support during the Reversing Heart Disease Summit. The event has now concluded, but you can still view the content by registering and purchasing the videos, transcripts, and audio files, which you can keep forever. Click Here for more information. This week, Dr. Kahn is focusing on exciting new results announced at the American College of Cardiology. A new oral cholesterol medication (PCKS9 inhibitor) from Merck looks very promising, and there is a buzz around a new strategy for Afib ablation. However, the biggest ripple was caused by an outcomes study of a non-statin medication called bempedoic acid or Nexletol in patients who are unable to take statins. This study is a great victory for providing more tools in the toolbox of advanced heart care.
Released:
Mar 17, 2023
Format:
Podcast episode
Titles in the series (100)
Impactful Veganism with Amber Poupore: In the city of Detroit no one works harder in the natural health restaurant world than our guest Amber Poupore. Her spirit, passion and excellent food is legendary at her 2 restaurants and thriving catering business. We talk about how she got to this... by Heart Doc VIP with Dr. Joel Kahn